The institutions that shaped oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

To launch our July coverage highlighting institutions, here is a collection of articles by our contributors about their history:

Spotlight: Imagining Roswell Park, the world’s first cancer research center
By Roswell Park Comprehensive Cancer Center | March 25, 2021

New: Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011
By Seattle Cancer Care Alliance | June 28, 2021

The Story of City of Hope
By City of Hope Comprehensive Cancer Center | February 23, 2021

The history of The Cancer Letter
By The Cancer Letter | January 1, 2021

MUSC Hollings Cancer Center awarded NCI designation
By MUSC Hollings Cancer Center | February 1, 2021

History of the American Society of Clinical Oncology and Progress Against Cancer
By ASCO | January 11, 2021

History of the AACR
By AACR | January 27, 2021

GOG History
By The GOG Foundation, Inc. and GOG Partners | June 17, 2021

National Breast Cancer Coalition Accomplishments and Milestones
By National Breast Cancer Coalition | May 7, 2021

Rutgers Cancer Institute’s 2019 redesignation: New Jersey’s only Comprehensive Cancer Center
By Rutgers Cancer Institute of New Jersey | May 4, 2021

SWOG: Public Powered Cancer Research Since 1956
By SWOG | April 20, 2021

Bob Young: NCCN is a case study in keeping what works and discarding what doesn’t
By The Cancer Letter | March 12, 2021


Recent contributions

Robert K. Stuart to retire from MUSC Hollings after more than 30 years
By MUSC Hollings Cancer Center | June 28, 2021

Photo Archive: Fox Chase Founders
By Fox Chase Cancer Center | July 1, 2021

Primary source: What Does It Mean to Be an Oncology Nurse? Reexamining the Life Cycle Concepts From 1994-2010
By Oncology Nursing Society | July 1, 2021


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available. 

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login